Briefing Book for the Meeting of the FDA Safety and Risk Management Committee

Docket Number:

FDA-2010-N-0001

CHPA does not believe scheduling of dextromethorphan under the Controlled Substances Act is warranted. The prevalence and scope of reported abuse is limited. CHPA believes that there are more effective interventions to address OTC cough medicine abuse.